Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma

NCT05844033 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05844033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05844033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
August 1, 2023
Completion date
March 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, multiple myeloma